1
What is the evidence distinguishing placental versus constitutional FGR using Doppler, biometry, and biomarkers?
2
What are the PORTO and TRUFFLE trial criteria for FGR surveillance and how do they inform delivery timing?
3
What is the evidence for the cerebroplacental ratio as a predictor of adverse perinatal outcome in late-onset FGR?
4
How does absent versus reversed end-diastolic flow in the umbilical artery change delivery decision-making by gestational age?
5
What is the role of ductus venosus Doppler in the terminal stages of fetal compromise and what does the a-wave predict?
6
What is the evidence for the ISUOG staging system for FGR and how does it compare to the Delphi consensus?
7
What is the pathophysiology of brain-sparing and at what point does it fail to protect the fetal brain?
8
What is the evidence on expectant management versus delivery for early-onset FGR between 26 and 32 weeks?
9
What biomarkers — sFlt-1, PlGF, PAPP-A — have the strongest predictive value for early-onset FGR?
10
What is the recurrence risk of FGR and what interventions have evidence for prevention in a subsequent pregnancy?